Teva (TEVA) Cuts FY11 EPS, Sales Outlook on Call
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Join SI Premium – FREE
On its Q3 conference call, a Teva (Nasdaq: TEVA) exec said the company expects to report FY11 EPS of $4.92-$5.02 on sales of $18.3-$18.6 billion, down from prior guidance of $4.90-$5.20 and $18.5-$19 billion.
The Street is currently looking for FY11 EPS of $5.03 on sales of $18.48 billion.
The Street is currently looking for FY11 EPS of $5.03 on sales of $18.48 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
Create E-mail Alert Related Categories
Conference Calls, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
